Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antibacterial activity against Escherichia coli at 100 ug after 24 hr by cup-plate method | ChEMBL. | No reference | |
Activity (functional) | = 9.78 % | Antimalarial activity against Plasmodium yoelii N-67 infected Swiss mouse assessed as parasitemia at 200 mg/kg, ip qd administered 4 days measured 24 hr post last treatment (Rvb = 12.36 +/- 1.14 %) | ChEMBL. | No reference |
Activity (functional) | = 17.5 % | Antimalarial activity against Plasmodium yoelii N-67 infected Swiss mouse assessed as parasitemia at 200 mg/kg, ip qd administered 4 days measured on day 7 (Rvb = 19.5 +/- 0.76 %) | ChEMBL. | No reference |
MST (functional) | = 6.8 day | Antimalarial activity against Plasmodium yoelii N-67 infected Swiss mouse assessed as mean survival time at 200 mg/kg, ip qd administered 4 days measured 24 hr post last treatment (Rvb = 8.2 +/- 0.86 days) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.